NR3C2 and Insulin resistance: Thus, excess ROS production, as a modulator of mineralocorticoid receptor activity [14] and known to be elevated in cardiometabolic disease, conceivably plays an important role in the pathogenesis of vascular insulin resistance and dysfunction.